Nimolancim
Nimolancim: A Cuban-developed cancer drug recently approved in Russia, marking a significant advancement in targeted tumor treatments internationally.
![Cuban-Developed Cancer Drug Gains Approval in Russia for Specific Tumor Treatments]()
Cuban-Developed Cancer Drug Gains Approval in Russia for Specific Tumor Treatments
Published on 10/19/2026
